GGrantIndex
Sort

141,003 grants matching cytokine

Epithelial progenitor cells for lung repair and regeneration

$664,141
Barry R Stripp · Cedars-Sinai Medical Center · R01 · FY2017 · HL

Epithelial progenitor cells for lung repair and regeneration

$664,141
Barry R Stripp · Cedars-Sinai Medical Center · R01 · FY2020 · HL

Epithelial progenitor cells for lung repair and regeneration

$664,141
Barry R Stripp · Cedars-Sinai Medical Center · R01 · FY2018 · HL

Epithelial progenitor cells for lung repair and regeneration

$664,141
Barry R Stripp · Cedars-Sinai Medical Center · R01 · FY2019 · HL

Optimization of small molecule immunomodulators as combination therapy for IBD

$664,128
Moustafa Gabr · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · DK

Oral microbiome and inflammatory status in antimicrobially-treated oral cancer patients

$664,088
Yvonne L Kapila · University Of California Los Angeles · R01 · FY2022 · CA

Tfh responses to novel vaccine candidates and protection from pediatric falciparum malaria

$664,076
Jonathan D. Kurtis · Brown University · R01 · FY2019 · AI

BAFF-R CAR T cell therapy for ALL

$664,070
Larry W Kwak · Beckman Research Institute/City Of Hope · R01 · FY2023 · CA

Rapid Immune Restoration and Lung Injury in HIV/TB

$664,038
Gregory P. Bisson · University Of Pennsylvania · R01 · FY2019 · AI

Image-guided cancer therapy using heat activatable CAR T cells

$664,037
Stanislav Y Emelianov · Georgia Institute Of Technology · R01 · FY2023 · EB

Inflammation And Submucosal Glands During Esophageal Injury And Repair

$664,035
Katherine Garman · Case Western Reserve University · P01 · FY2023 · CA

Microfluidic Functional Immunophenotyping of Pediatric Patients Following Cardiop

$664,017
Jianping Fu · University Of Michigan At Ann Arbor · R01 · FY2017 · HL

Clinical safety and pharmacokinetic studies of intravaginal rings releasing multiple antiretrovirals

$664,015
Thomas J. Smith · Auritec Pharmaceuticals, Inc. · R44 · FY2015 · HD

Comprehensive Characterization of Glycosylation Alterations in Alzheimer's Disease

$664,010
Angela M Zivkovic · University Of California At Davis · R01 · FY2020 · AG

Comprehensive Characterization of Glycosylation Alterations in Alzheimer’s Disease

$664,010
Angela M Zivkovic · University Of California At Davis · R01 · FY2019 · AG

Comprehensive Characterization of Glycosylation Alterations in Alzheimer's Disease

$664,010
Angela M Zivkovic · University Of California At Davis · R01 · FY2021 · AG

Optimizing immunoradiotherapy for HNSCC

$663,994
Joseph A Califano · University Of California, San Diego · R01 · FY2025 · CA

Sirtuins and Host Metabolism in TB Pathogenesis and Treatment

$663,956
Hardy Kornfeld · Univ Of Massachusetts Med Sch Worcester · R01 · FY2021 · HL

IL-27R signaling as a negative regulator of innate and adaptive anti-cancer immunity in hepatocellular carcinoma

$663,926
Ekaterina Koltsova · Cedars-Sinai Medical Center · R01 · FY2022 · CA

OLIGOSACCHARIDE STRUCTURE & FUNCTION IN RECOGNITION

$663,919
Jacques U Baenziger · Washington University · R01 · FY2010 · CA

Precision Medicine Approach to Glucocortisteroids in Sepsis

$663,908
Sachin Yende · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · GM

Microbiome-induced intestinal Th17 cells and microbiome independent gamma delta T cells improve fracture healing

$663,901
Roberto Pacifici · Emory University · R01 · FY2025 · AR

Mechanisms of Ebola virus-mediated inflammatory activation linked to pathogenesis

$663,887
Michael A Barry · Mayo Clinic Rochester · R01 · FY2020 · AI

MCLENA-1: A Clinical Trial for the Assessment of Lenalidomide in Amnestic MCI Patients

$663,871
Marwan Noel Sabbagh · St. Joseph'S Hospital And Medical Center · R01 · FY2022 · AG

Targeting novel therapeutic vulnerabilities in LKB1 mutant tumors.

$663,862
Nabeel Bardeesy · Massachusetts General Hospital · R01 · FY2022 · CA